JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB288710

Human SGIP1 knockout SK-N-FI cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SGIP1 KO cell line available to order. KO validated. Free of charge wild type control available. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human SGIP1 knockout SK-N-FI cell line (AB288710)
  • Sanger seq

Supplier Data

Sanger Sequencing - Human SGIP1 knockout SK-N-FI cell line (AB288710)

Homozygote,76 bp deletion

Key facts

Cell type

SK-N-FI

Species or organism

Human

Tissue

Bone marrow

Form

Liquid

form

Knockout validation

Sanger Sequencing

Disease

Neuroblastoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Sanger seq": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Although we aim to provide customers with a homozygous clone, feasibility will be dependent on the biology of the protein. Should only heterozygous edits be achieved, you will be notified of the outcome and be asked to confirm whether the cell line is acceptable. All clones will be accompanied with DNA sequencing data, and the mutation description.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab288710-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab288716 Human wild-type SK-N-FI cell line", "number":"AB288710-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab288710 Human SGIP1 knockout SK-N-FI cell line", "number":"AB288710-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab288710-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab288710 Human SGIP1 knockout SK-N-FI cell line", "number":"AB288710-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SGIP1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines

All seeding densities should be based on cell counts gained by established methods., Cells should be passaged when they have achieved 80-90% confluence (approx 8x104-1x105 cells/cm2).

Culture medium

DMEM + 0.1 mM NEAA + 10 % FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The SH3-domain GRB2-like endophilin B1 interacting protein 1 commonly known as SGIP1 weighs around 118 kDa. This protein is involved in clathrin-mediated endocytosis processes. SGIP1 interacts with adaptor proteins playing a role in endocytosis by modulating the internalization of membrane components into the cell. Researchers have identified its expression mainly in the brain especially in neurons and it has been observed to a lesser extent in other tissues.
Biological function summary

SGIP1 plays a role in neural activities by contributing to the regulation of synaptic vesicle recycling. It assists in neurotransmitter uptake influencing synaptic transmission efficiency. SGIP1 interacts with components of endocytic vesicle formation forming part of a larger protein complex that includes clathrin and dynamin. This complex is necessary for the vesicle scission and cargo selection during endocytosis.

Pathways

SGIP1 is involved in the clathrin-mediated endocytosis pathway essential for recycling synaptic vesicles and maintaining synaptic function. It operates alongside proteins like dynamin 1 a GTPase important for vesicle fission. In the context of synaptic function SGIP1 engages with pathways connected to neurotransmitter uptake impacting neuronal communication and plasticity.

SGIP1 has been associated with neurological conditions such as schizophrenia and Alzheimer's disease. Changes in its normal function may influence synaptic vesicle recycling leading to synaptic dysfunction observed in these disorders. The protein dysbindin-1 known for its connection to schizophrenia interacts with SGIP1 indicating potential overlap in their pathological roles. Understanding these interactions might provide insight into novel therapeutic strategies for these diseases.

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com